AEterna Zentaris Inc. (Nasdaq: AEZS) plans to initiate its Phase 3 program in benign prostatic hyperplasia (BPH) before year-end with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE